NRx Pharmaceuticals' stock jumps following new analysis of its potential Covid-19 drug
November 29, 2021 at 13:57 PM EST
A new analysis compared the Radnor firm's potential treatment to other therapies now being used to treat Covid-19.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|